Worth reading
76Important
Scored from 5 of 6 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
-6199
Millions of yen (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Presentation materials on financial resultsFiscal year ending March 202610 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥130,918 million-4.5%
Operating profit¥4,882 million-38.4%
Ordinary income¥4,920 million-39.9%
Net income¥509 million -91.9%net profit attributable to owners of the parent
Operating profit margin3.7 %
Results for the three months of the current quarter
First quarter
Net Sales
¥32,240 million
Operating profit
¥1,806 million
Ordinary income
¥1,838 million
Net income
-1,473 Millions of yen quarterly net loss attributable to owners of the parent
Second quarter
Net Sales
¥33,029 million
Operating profit
¥1,380 million
Ordinary income
¥1,366 million
Net income
¥814 million
Third quarter
Net Sales
¥34,573 million
Operating profit
¥2,455 million
Ordinary income
¥2,434 million
Net income
¥1,982 million
Fourth quarter
Net Sales
¥31,074 million
Operating profit
¥-759 million
Ordinary income
¥-719 million
Net income
¥-814 million
Full-year earnings forecast
Fiscal year ending March 2027
Net Sales
¥132,000 million
Operating profit
¥8,800 million
Ordinary income
¥8,400 million
Net income
¥5,200 million net profit attributable to owners of the parent
Operating profit margin
6.7 %
Ordinary income margin
6.4 %
Net profit margin
3.9 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Apparel business restructuring is progressing as plannedBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Decrease in revenue due to the discontinuation of the electronic components businessApproximately ¥2.9 billion (revenue)
- Inventory valuation losses in the apparel businessApproximately ¥1.9 billion
- Apparel business restructuring expenses¥-3,311 million
- Acquisition of Fixed Assets¥-12,149 million investing cash flow
New initiatives
- Establishing a resource circulation model centered on a circular factory
- Launching new production lines for medical and semiconductor products
- Expanding sales in Europe, the Americas and APAC, excluding China
- Consolidating apparel brands, reducing SKUs, revising prices and shifting to D2C
- Increasing engineering plastics production capacity and constructing a new building for the fiscal year ending March 2027
- Adding plastic film manufacturing equipment and upgrading existing facilities
Key KPIsA metric the company considers important as a management benchmark.
- Industrial products sales volumeRecord highYear on year against the same period last yearNew record high
- Equity ratio72.8 %Year-on-year change (points)-1.8
- BPS (book value per share)¥3,565.39Year-on-year change-101.81
- Achievement rate for the fiscal 2026 target for improving apparel restructuring operating income and loss93 %
- Achievement rate for the focused specialization strategy target90 %
- Achievement rate for the value chain transformation target101 %
- Achievement rate for other transformation targets89 %
Segment results
Functional Solutions
Net Sales
¥47,543 million
Year-on-year change in revenue-8.9
Operating profit
¥7,234 million
Year-on-year operating profit growth0.4
Medical
Net Sales
¥13,197 million
Year-on-year change in revenue1.9
Operating profit
¥1,474 million
Year-on-year operating profit growth-39.3
Apparel
Net Sales
¥58,597 million
Year-on-year change in revenue-3.6
Operating profit
¥-1,334 million
Year-on-year operating profit growthDeclined from ¥753 million in the previous fiscal year, resulting in a loss
Life Create
Net Sales
¥12,530 million
Year-on-year change in revenue4.4
Operating profit
¥1,232 million
Year-on-year operating profit growth24.7
Medium-term management plan targets
Target state for the apparel business in 2030
Operating profit margin10%
Annual inventory turnover4 turns
Shorten lead times50%
GVAProfitability
Medical BusinessEarly recovery to a 20% operating margin
Capital expenditures
¥12,527 million
Annual Dividend
Fiscal year ending March 2026
¥216 per share
Forecast for the fiscal year ending March 2027
¥216 per share
Breakdown
Regular dividend¥147 per share
Special dividend¥69 per share
Payout ratio
Targeting a payout ratio of 50% and DOE of at least 4.0%
Acquisition of treasury shares
Number of shares acquired¥1,153,400 thousand
Acquisition amount¥4,999,956 thousand
Acquisition period6 November 2025 to 24 March 2026 (completed on 12 March 2026)
| Item | Details |
|---|---|
| Document type | Presentation materials on financial results |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥130,918 million (YoY -4.5%) |
| Operating profit | ¥4,882 million (YoY -38.4%) |
| Ordinary income | ¥4,920 million (YoY -39.9%) |
| Net income | ¥509 million (net profit attributable to owners of the parent) (YoY -91.9%) |
| Operating profit margin | 3.7 % |
| Results for the three months of the current quarter | First quarter Net Sales ¥32,240 million / Operating profit ¥1,806 million / Ordinary income ¥1,838 million / Net income -1,473 Millions of yen (quarterly net loss attributable to owners of the parent) / Second quarter Net Sales ¥33,029 million / Operating profit ¥1,380 million / Ordinary income ¥1,366 million / Net income ¥814 million / Third quarter Net Sales ¥34,573 million / Operating profit ¥2,455 million / Ordinary income ¥2,434 million / Net income ¥1,982 million / Fourth quarter Net Sales ¥31,074 million / Operating profit ¥-759 million / Ordinary income ¥-719 million / Net income ¥-814 million |
| Full-year earnings forecast | Fiscal year ending March 2027 Net Sales ¥132,000 million / Operating profit ¥8,800 million / Ordinary income ¥8,400 million / Net income ¥5,200 million (net profit attributable to owners of the parent) / Operating profit margin 6.7 % / Ordinary income margin 6.4 % / Net profit margin 3.9 % |
| Self-assessment against the plan | Apparel business restructuring is progressing as planned |
| Segment results | Functional Solutions Net Sales ¥47,543 million / Year-on-year change in revenue -8.9 / Operating profit ¥7,234 million / Year-on-year operating profit growth 0.4 / Medical Net Sales ¥13,197 million / Year-on-year change in revenue 1.9 / Operating profit ¥1,474 million / Year-on-year operating profit growth -39.3 / Apparel Net Sales ¥58,597 million / Year-on-year change in revenue -3.6 / Operating profit ¥-1,334 million / Year-on-year operating profit growth Declined from ¥753 million in the previous fiscal year, resulting in a loss / Life Create Net Sales ¥12,530 million / Year-on-year change in revenue 4.4 / Operating profit ¥1,232 million / Year-on-year operating profit growth 24.7 |
| Breakdown of Factors Affecting the Change | Factors Decrease in revenue due to the discontinuation of the electronic components business / Amount Approximately ¥2.9 billion (revenue), Factors Inventory valuation losses in the apparel business / Amount Approximately ¥1.9 billion, Factors Apparel business restructuring expenses / Amount ¥-3,311 million, Factors Acquisition of Fixed Assets / Amount ¥-12,149 million (investing cash flow) |
| Key KPIs | Indicator name Industrial products sales volume / Value Record high / Year on year against the same period last year New record high, Indicator name Equity ratio / Value 72.8 % / Year-on-year change (points) -1.8 %, Indicator name BPS (book value per share) / Value ¥3,565.39 / Year-on-year change ¥-101.81, Indicator name Achievement rate for the fiscal 2026 target for improving apparel restructuring operating income and loss / Value 93 % / Year on year against the same period last year Not disclosed, Indicator name Achievement rate for the focused specialization strategy target / Value 90 % / Year on year against the same period last year Not disclosed, Indicator name Achievement rate for the value chain transformation target / Value 101 % / Year on year against the same period last year Not disclosed, Indicator name Achievement rate for other transformation targets / Value 89 % / Year on year against the same period last year Not disclosed |
| Medium-term management plan targets | Target state for the apparel business in 2030 Operating profit margin 10% / Annual inventory turnover 4 turns / Shorten lead times 50% / GVA Profitability / Medical Business Early recovery to a 20% operating margin |
| Annual Dividend | Fiscal year ending March 2026 ¥216 per share / Forecast for the fiscal year ending March 2027 ¥216 per share |
| Payout ratio | Targeting a payout ratio of 50% and DOE of at least 4.0% |
| Acquisition of treasury shares | Number of shares acquired ¥1,153,400 thousand / Acquisition amount ¥4,999,956 thousand / Acquisition period 6 November 2025 to 24 March 2026 (completed on 12 March 2026) |
| Capital expenditures | ¥12,527 million |
| New initiatives | Establishing a resource circulation model centered on a circular factory, Launching new production lines for medical and semiconductor products, Expanding sales in Europe, the Americas and APAC, excluding China, Consolidating apparel brands, reducing SKUs, revising prices and shifting to D2C, Increasing engineering plastics production capacity and constructing a new building for the fiscal year ending March 2027, Adding plastic film manufacturing equipment and upgrading existing facilities |
Items this document does not state (12)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue declined due to the impact of sales from the electronic components business, which was discontinued at the end of the previous fiscal year, lower overseas sales of plastic films, and lower sales through existing channels such as mass retailers in the apparel business. Operating income and ordinary income declined due to inventory valuation losses in the apparel business, stagnant sales in China and higher fixed costs, while net income was affected by restructuring expenses for the apparel business and other factors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.